Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-14-027200
Filing Date
2014-05-02
Accepted
2014-05-02 16:32:40
Documents
1
Group Members
ACCREDITED VENTURE CAPITAL, LLCPHARMAINVESTORS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v377103_sc13da.htm SC 13D/A 62583
  Complete submission text file 0001144204-14-027200.txt   64130
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Subject) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50777 | Film No.: 14809826
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
KANZER STEVE H (Filed by) CIK: 0001076653 (see all company filings)

Type: SC 13D/A